Inventor · disambiguated record
Richard Vandlen
Also filed as: VANDLEN RICHARD · VANDLEN RICHARD L
39 granted patents·43 pending applications·3,005 citations·filing 1984–2022
98Inventor score
Top patents by PatentIndex Score
82 records- 0197US7855275B2Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2009·Granted Dec 21, 2010·301 cites·63 claims
- 0297US7521541B2Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2005·Granted Apr 21, 2009·1.4k cites·68 claims
- 0396US6569645B2IL-17 homologous polypeptides and therapeutic uses thereofGENENTECH INC·Filed 2000·Granted May 27, 2003·89 cites·10 claims
- 0496US5641869AMethod for purifying heregulinGENENTECH INC·Filed 1995·Granted Jun 24, 1997·192 cites·17 claims
- 0595US9815880B2IL-22 Fc fusion proteinsGENENTECH INC·Filed 2016·Granted Nov 14, 2017·15 cites·18 claims
- 0695US5834229ANucleic acids vectors and host cells encoding and expressing heregulin 2-αGENENTECH INC·Filed 1994·Granted Nov 10, 1998·106 cites·40 claims
- 0795US5367060AStructure, production and use of heregulinGENENTECH INC·Filed 1992·Granted Nov 22, 1994·158 cites·27 claims
- 0894US6579520B2IL-17 related mammalian cytokine polypeptides (IL-17E)GENENTECH INC·Filed 2001·Granted Jun 17, 2003·76 cites·8 claims
- 0994US5859206AAntibodies specific for heregulin 2-αGENENTECH INC·Filed 1995·Granted Jan 12, 1999·87 cites·27 claims
- 1094US5856110AMethod of using HRG2-α to stimulate P185HeR2GENENTECH INC·Filed 1995·Granted Jan 5, 1999·81 cites·32 claims
- 1194US5840525ANucleic acids, vectors and host cells encoding heregulinGENENTECH INC·Filed 1995·Granted Nov 24, 1998·108 cites·29 claims
- 1292US4609725ACardiac atrial peptidesMERCK & CO INC·Filed 1984·Granted Sep 2, 1986·96 cites·4 claims
- 1391US10160793B2Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteinsGENENTECH INC·Filed 2014·Granted Dec 25, 2018·9 cites·30 claims
- 1490US10087227B2Nucleic acids encoding IL-22 Fc fusion proteinsGENENTECH INC·Filed 2016·Granted Oct 2, 2018·5 cites·26 claims
- 1589US6620413B1OB protein-polymer chimerasGENENTECH INC·Filed 1996·Granted Sep 16, 2003·121 cites·25 claims
- 1688US6953842B2Antibodies to heregulin 2GENENTECH INC·Filed 2001·Granted Oct 11, 2005·9 cites·7 claims
- 1787US6696290B2ErbB2 and ErbB4 Chimeric Heteromultimeric AdhesinsGENENTECH INC·Filed 1999·Granted Feb 24, 2004·72 cites·9 claims
- 1886US9803002B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2014·Granted Oct 31, 2017·6 cites·58 claims
- 1984US8034342B2Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17EGENENTECH INC·Filed 2009·Granted Oct 11, 2011·3 cites·7 claims
- 2082US8338132B2Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereofCHEN JIAN·Filed 2009·Granted Dec 25, 2012·3 cites·8 claims
- 2181US11155591B2Methods of treating acute pancreatitis using IL-22 fc fusion proteinsGENENTECH INC·Filed 2018·Granted Oct 26, 2021·1 cites·27 claims
- 2278US5759807AProcess for producing relaxinGENENTECH INC·Filed 1995·Granted Jun 2, 1998·50 cites·37 claims
- 2378US2023063741A1IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USEGENENTECH INC·Filed 2022·Application pending·0 cites
- 2476US6399746B1Structure, production and use of heregulin 2 ligandsGENENTECH INC·Filed 1998·Granted Jun 4, 2002·26 cites·5 claims
- 2573US5464756AProcesses and compositions for the isolation of human relaxinGENENTECH INC·Filed 1992·Granted Nov 7, 1995·31 cites·15 claims
- 2671US11332507B2IL-22 Fc fusion proteinsGENENTECH INC·Filed 2018·Granted May 17, 2022·0 cites·13 claims
- 2771US11130791B2Methods for treating metabolic syndrome using IL-22 Fc fusion proteinsGENENTECH INC·Filed 2018·Granted Sep 28, 2021·0 cites·29 claims
- 2871US9884126B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2014·Granted Feb 6, 2018·1 cites·26 claims
- 2969US11136365B2Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteinsGENENTECH INC·Filed 2018·Granted Oct 5, 2021·0 cites·28 claims
- 3069US7659368B2ErbB2 and ErbB3 chimeric heteromultimer adhesinsGENENTECH INC·Filed 2003·Granted Feb 9, 2010·4 cites·12 claims
- 3168US7601827B2Polynucleotides encoding polypeptides that bind to the P185HER2 receptorGENENTECH INC·Filed 2005·Granted Oct 13, 2009·0 cites·4 claims
- 3268US2018000962A1Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2017·Application pending·0 cites
- 3367US2015266953A1Il-17 homologous polypeptides and therapeutic uses thereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 3467US2015141283A1Il-17 homologous polypeptides and therapeutic uses thereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 3566US10584181B2Methods of making and using multispecific antibody panels and antibody analog panelsSCHEER JUSTIN·Filed 2010·Granted Mar 10, 2020·1 cites·30 claims
- 3666US2006019307A1Interleukin-8 homologous polypeptides and therapeutic uses thereofGENENTECH INC·Filed 2004·Application pending·0 cites
- 3766US2015017188A1Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2014·Application pending·0 cites
- 3866US2009291097A1IL-17 homologous polypeptides and therapeutic uses thereofCHEN JIAN·Filed 2007·Application pending·0 cites
- 3965US10584155B2Pharmaceutical compositions of IL-22 Fc fusion proteinsGENENTECH INC·Filed 2017·Granted Mar 10, 2020·0 cites·29 claims
- 4065US2008160021A1Il-17 homologous polypeptides and therapeutic uses thereofCHEN JIAN·Filed 2007·Application pending·0 cites
- 4164US10544198B2Methods of accelerating or improving wound healing using IL-22 FC fusion proteinsGENENTECH INC·Filed 2017·Granted Jan 28, 2020·0 cites·40 claims
- 4264US8273703B2IL-17 receptor-like polypeptides and therapeutic uses thereofCHEN JIAN·Filed 2006·Granted Sep 25, 2012·0 cites·35 claims
- 4363US2009087429A1IL-17 homologous polypeptides and therapeutic uses thereofCHEN JIAN·Filed 2007·Application pending·0 cites
- 4463US2009136491A1IL-17 homologous polypeptides and therapeutic uses thereofCHEN JIAN·Filed 2007·Application pending·0 cites
- 4563US2009117114A1IL-17 homologous polypeptides and therapeutic uses thereofCHEN JIAN·Filed 2007·Application pending·0 cites
- 4662US2009227017A1Nucleic acids encoding receptor for il-17 homologous polypeptides and uses thereofCHEN JIAN·Filed 2009·Application pending·0 cites
- 4762US2009068178A1Compositions and Methods for the Treatment of Tumor of Hematopoietic OriginGENENTECH INC·Filed 2008·Application pending·0 cites
- 4862US2014323706A1Nucleic acids encoding receptor for il-17 homologous polypeptides and uses thereofGENENTECH INC·Filed 2013·Application pending·0 cites
- 4961US8226935B2ErbB2 and ErbB3 chimeric heteromultimer receptorsFITZPATRICK VINCENT DANIAL·Filed 2009·Granted Jul 24, 2012·0 cites·5 claims
- 5061US2004043397A1IL-17 homologous polypeptides and therapeutic uses thereofGENENTECH INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Richard Vandlen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →